Progenics Pharmaceuticals competitorsClear all

Progenics Pharmaceuticals's top competitors include Acerta Pharma, Ablynx and Halozyme Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Progenics Pharmaceuticals
Progenics Pharmaceuticals
Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.
Acerta Pharma
Acerta Pharma
Acerta Pharma is a biopharmaceutical company.
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Founding Date
Founding Date
1986
Founding Date
2013
Founding Date
2001
Founding Date
1998
Type
Type
Subsidiary
Type
Subsidiary
Type
Subsidiary
Type
Public
Tags
Locations
Locations
New York, US HQ
Billerica, US
Locations
South San Francisco, US HQ
Oss, NL
Oss, NL
Locations
Gent, BE HQ
Gent, BE
Locations
San Diego, US HQ
Employees
Employees
10533% increase
Employees
197
Employees
3821% decrease
Employees
1363% increase
Twitter followers
Twitter followers
292
Twitter followers
N/A
Twitter followers
261
Twitter followers
235
Alexa Website Rank
Alexa Website Rank
428737
Alexa Website Rank
N/A
Alexa Website Rank
389080
Alexa Website Rank
368178
Employee Rating
Employee Rating
2.8
Employee Rating
3.5
Employee Rating
3.2
Employee Rating
3.4

Financial

Revenue (est.)
Revenue (est.)
$35m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
€85.2m (FY, 2016)
Revenue (est.)
$267.6m (FY, 2020)
Cost of goods
Cost of goods
$3.2m (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$43.4m (FY, 2020)
Gross profit
Gross profit
$31.8m (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
$224.2m (FY, 2020)
Net income
Net income
($68.6m) (FY, 2019)
Net income
N/A
Net income
(€1.1m) (FY, 2016)
Net income
$129.1m (FY, 2020)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
50 (Q2, 2017)
Patents (US)
43 (FY, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 60m
Total funding raised
$ 498.8m
Total funding raised
$ 45m
For sources of this data, please see the company profile

View company profiles

Acerta Pharma
HQ
South San Francisco, US

Acerta Pharma is a biopharmaceutical company.

View company
Ablynx
HQ
Gent, BE

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

View company
Halozyme Therapeutics
HQ
San Diego, US
Employees
136↑ 3% increase

Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.

View company